Daily oxymetazoline cream demonstrates high and sustained efficacy in patients with persistent erythema of rosacea through 52 weeks of treatment

Publication date: September 2018

Source: Journal of the American Academy of Dermatology, Volume 79, Issue 3

Author(s): Michael H. Gold, Mark Lebwohl, Brian S. Biesman, Deanne Mraz Robinson, Lei Luo, David R. Berk, Gurpreet Ahluwalia, Nancy Alvandi

https://ift.tt/2vKSr7d